// App-Quantinova.ai

195 : Defining the role of PAK7 variants in melanoma

Researchers

Presenter

  • Kyle M. LaPak

Principal Investigators

  • Michael A. Gross

  • Denny C. Vroom

  • Greg B. Lesinski

  • William E. Carson

  • Christin E. Burd

Medical Centers

  • The Ohio State Univerisity, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Mouse double minute 2 homolog

  • Raf-1 proto-oncogene, serine/threonine kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved